Real-world evidence of urinary tract infections and genital tract infections with sodium-glucose cotransporter-2 inhibitors (SGLT2i) alone or in combination with dipeptidyl peptidase-4 inhibitors (DPP4i) in individuals with type-2 diabetes mellitus in India.

Singh NK, Singh AK, Gupta A, Phatak SR, Sharma AK, Patni B, Gera N, M S, Shah S, Sengupta S, Saxena AK, Saboo B, Tewari A, Gokhale PD, Shah K, Naik D, Radhakrishnan C, L S, Swain S, Gautam A, Chhabra M, Kedia AK, Aslam M, Jagadeesha A, Rodrigues L, Agrawal P, Borpuzari R, Pursnani N, Ghosh B, Nageshappa MK, Malpani SH, B HD, Jha SC, Singha NG, S S D, Srivastava A, Sheohare R, Lamba S, A P, Kushe MS, Mithal A, Joshi SR, Saboo B, Sharma R, Gupta R

Open source

DOI: 10.1186/s12902-026-02304-z
Published: 2026 May 20
Container: BMC endocrine disorders
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12902-026-02304-z,
  title = {Real-world evidence of urinary tract infections and genital tract infections with sodium-glucose cotransporter-2 inhibitors (SGLT2i) alone or in combination with dipeptidyl peptidase-4 inhibitors (DPP4i) in individuals with type-2 diabetes mellitus in India.},
  author = {Singh NK and Singh AK and Gupta A and Phatak SR and Sharma AK and Patni B and Gera N and M S and Shah S and Sengupta S and Saxena AK and Saboo B and Tewari A and Gokhale PD and Shah K and Naik D and Radhakrishnan C and L S and Swain S and Gautam A and Chhabra M and Kedia AK and Aslam M and Jagadeesha A and Rodrigues L and Agrawal P and Borpuzari R and Pursnani N and Ghosh B and Nageshappa MK and Malpani SH and B HD and Jha SC and Singha NG and S S D and Srivastava A and Sheohare R and Lamba S and A P and Kushe MS and Mithal A and Joshi SR and Saboo B and Sharma R and Gupta R},
  year = {2026},
  journal = {BMC endocrine disorders},
  doi = {10.1186/s12902-026-02304-z},
  url = {https://doi.org/10.1186/s12902-026-02304-z}
}

RIS

TY  - JOUR
TI  - Real-world evidence of urinary tract infections and genital tract infections with sodium-glucose cotransporter-2 inhibitors (SGLT2i) alone or in combination with dipeptidyl peptidase-4 inhibitors (DPP4i) in individuals with type-2 diabetes mellitus in India.
AU  - Singh NK
AU  - Singh AK
AU  - Gupta A
AU  - Phatak SR
AU  - Sharma AK
AU  - Patni B
AU  - Gera N
AU  - M S
AU  - Shah S
AU  - Sengupta S
AU  - Saxena AK
AU  - Saboo B
AU  - Tewari A
AU  - Gokhale PD
AU  - Shah K
AU  - Naik D
AU  - Radhakrishnan C
AU  - L S
AU  - Swain S
AU  - Gautam A
AU  - Chhabra M
AU  - Kedia AK
AU  - Aslam M
AU  - Jagadeesha A
AU  - Rodrigues L
AU  - Agrawal P
AU  - Borpuzari R
AU  - Pursnani N
AU  - Ghosh B
AU  - Nageshappa MK
AU  - Malpani SH
AU  - B HD
AU  - Jha SC
AU  - Singha NG
AU  - S S D
AU  - Srivastava A
AU  - Sheohare R
AU  - Lamba S
AU  - A P
AU  - Kushe MS
AU  - Mithal A
AU  - Joshi SR
AU  - Saboo B
AU  - Sharma R
AU  - Gupta R
PY  - 2026
JO  - BMC endocrine disorders
DO  - 10.1186/s12902-026-02304-z
UR  - https://doi.org/10.1186/s12902-026-02304-z
ER  -

APA

NK, S., AK, S., A, G., SR, P., AK, S., B, P., N, G., S, M., S, S., S, S., AK, S., B, S., A, T., PD, G., K, S., D, N., C, R., S, L., S, S., A, G., M, C., AK, K., M, A., A, J., L, R., P, A., R, B., N, P., B, G., MK, N., SH, M., HD, B., SC, J., NG, S., D, S. S., A, S., R, S., S, L., P, A., MS, K., A, M., SR, J., B, S., R, S., & R, G. (2026). Real-world evidence of urinary tract infections and genital tract infections with sodium-glucose cotransporter-2 inhibitors (SGLT2i) alone or in combination with dipeptidyl peptidase-4 inhibitors (DPP4i) in individuals with type-2 diabetes mellitus in India.. BMC endocrine disorders. https://doi.org/10.1186/s12902-026-02304-z

Source records

pubmed · retrieved 2026-09-26T21:04:05.582Z
doaj · retrieved 2026-09-26T21:04:05.589Z